top of page
VO2 max test. Sportswoman with mask running on treadmill. Female athlete in sports science

PX3 Performance Research

AFA white.png

Physiological Effects of Wearing Athletic Mouth Pieces While Performing Various Exercises

Military Medicine, Volume 183, Issue suppl_1, March-April 2018, Pages 510–515,

Michael F Zupan, USAFA, BSC (Ret.), Dyana L Bullinger, MS, Brenda Buffington, EdD, Caroline Koch, BS, Samantha Parker, BS, Steve Fragleasso, BS, Taylor Fogg, Shay Rasmussen-Woerner, BS

Road Biking

9% increase in endurance

Track and Field Athlete being ready in the blocks alone with no competition, sprinter, emp

12% increase in speed

Barbell with Weights

8% increase in strength

Sleep Apnea Diagnostic medical device Kit attached to the finger and the human nose, which


Logo_PX3 Greater than.png

PX3, a fully customized Mandibular Advancement Device (MAD), is clinically validated to treat mild to moderate obstructive sleep apnea (OSA), and supported by numerous studies on MADs and oral appliance therapy for the effectiveness in treating mild to moderate OSA.


While CPAP therapy remains a top option for patients suffereing from OSA, PX3 offers a viable alternative for those unable to tolerate CPAP or seeking non-surgical or non-pharmalogical solutions.


PX3 is also an ideal solution for high-performers without an OSA diagnosis but facing sleep deprivation, high-pressure, and high-stress, aiming to improve their sleep quality and ability to perform.

Before deciding on any treatment options, it is imperative that you first consult with a qualified medical or dental professional.  As with any treatment solution, there are certain limitations and potential risks that you need to discuss and consider with your healthcare provider.  

Mandibular advancement devices in obstructive sleep apnea: an updated review

Study 2

Efficacy of mandibular advancement device in the treatment of obstructive sleep apnea syndrome

Study 3

Mandibular advancement device use in obstructive sleep apnea: ORCADES study 5-year follow-up data

bottom of page